Browne L Daniel
Insider CIK 1597583 · RVNC CEO and President, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RVNC Revance Therapeutics, Inc. | J Other | 2019-06-28 | 2019-07-02 | 1,000 | $11.02 | $11.0K | 152,193 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2019-03-18 | 2019-03-19 | 11,613 | $15.51 | $180.1K | 151,193 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2019-03-15 | 2019-03-19 | 3,256 | $15.45 | $50.3K | 165,687 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2019-03-15 | 2019-03-19 | 2,881 | $15.45 | $44.5K | 162,806 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2019-02-19 | 2019-02-20 | 5,446 | $17.68 | $96.3K | 168,943 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2019-02-15 | 2019-02-20 | 3,154 | $17.69 | $55.8K | 174,389 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2019-01-24 | 2019-01-25 | 200,000 | — | $0 | 200,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2019-01-24 | 2019-01-25 | 35,000 | — | $0 | 177,543 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | J Other | 2018-06-29 | 2018-07-03 | 668 | $23.33 | $15.6K | 142,543 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2018-03-16 | 2018-03-16 | 20,000 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2018-03-16 | 2018-03-16 | 5,452 | $31.43 | $171.4K | 141,875 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2018-03-16 | 2018-03-16 | 20,000 | $2.55 | $51.0K | 147,327 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2018-03-15 | 2018-03-16 | 1,000 | $32.80 | $32.8K | 130,208 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2018-03-15 | 2018-03-16 | 2,881 | $31.65 | $91.2K | 127,327 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2018-03-07 | 2018-03-09 | 27,283 | $31.43 | $857.5K | 131,208 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2018-02-15 | 2018-02-16 | 3,074 | $31.75 | $97.6K | 158,491 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2018-02-08 | 2018-02-09 | 169,000 | — | $0 | 169,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2018-02-08 | 2018-02-09 | 28,250 | — | $0 | 161,565 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | J Other | 2017-12-29 | 2018-01-03 | 127 | $22.99 | $2.9K | 133,315 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2017-11-22 | 2017-11-24 | 7,600 | $24.94 | $189.5K | 133,188 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2017-10-18 | 2017-10-20 | 7,662 | $26.16 | $200.4K | 140,788 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2017-09-20 | 2017-09-22 | 7,600 | $23.58 | $179.2K | 148,450 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2017-08-23 | 2017-08-25 | 331 | — | $0 | 10,990 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2017-08-23 | 2017-08-25 | 22,800 | $22.76 | $518.9K | 156,050 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2017-08-23 | 2017-08-25 | 331 | $2.55 | $844 | 178,850 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | J Other | 2017-06-30 | 2017-07-05 | 1,000 | $18.32 | $18.3K | 178,519 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2017-06-12 | 2017-06-14 | 8,300 | — | $0 | 11,321 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2017-06-12 | 2017-06-14 | 8,300 | $2.55 | $21.2K | 177,519 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2017-05-30 | 2017-05-31 | 5,000 | — | $0 | 19,621 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2017-05-30 | 2017-05-31 | 5,000 | $2.55 | $12.8K | 169,219 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2017-05-24 | 2017-05-24 | 19,713 | $20.35 | $401.2K | 164,219 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2017-05-22 | 2017-05-24 | 12,287 | $20.20 | $248.2K | 183,932 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2017-03-16 | 2017-03-17 | 3,171 | $19.20 | $60.9K | 196,219 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2017-02-22 | 2017-02-24 | 9,768 | $20.56 | $200.8K | 200,659 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2017-02-22 | 2017-02-24 | 1,269 | $20.70 | $26.3K | 199,390 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2017-01-26 | 2017-01-30 | 155,000 | — | $0 | 155,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2017-01-26 | 2017-01-30 | 25,800 | — | $0 | 210,427 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2017-01-25 | 2017-01-27 | 12,000 | $19.78 | $237.4K | 184,627 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | J Other | 2016-12-30 | 2017-01-03 | 1,000 | $11.58 | $11.6K | 196,627 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2016-12-28 | 2016-12-30 | 12,000 | $20.94 | $251.3K | 195,627 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2016-11-25 | 2016-11-25 | 11,178 | $17.86 | $199.6K | 208,449 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2016-11-25 | 2016-11-25 | 822 | $18.70 | $15.4K | 207,627 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2016-10-26 | 2016-10-28 | 12,000 | $14.85 | $178.2K | 219,627 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2016-05-19 | 2016-05-23 | 12,050 | $17.11 | $206.2K | 231,627 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2016-02-09 | 2016-02-11 | 175,000 | — | $0 | 175,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2016-02-09 | 2016-02-11 | 25,000 | — | $0 | 243,677 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | J Other | 2015-12-31 | 2016-01-04 | 262 | $27.00 | $7.1K | 218,677 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2015-12-30 | 2016-01-04 | 12,045 | — | $0 | 24,621 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2015-12-30 | 2016-01-04 | 12,045 | $2.55 | $30.7K | 218,415 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | J Other | 2015-06-30 | 2015-07-02 | 1,000 | $14.16 | $14.2K | 1,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2015-05-19 | 2015-05-21 | 12,025 | $25.94 | $311.9K | 205,101 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2015-01-28 | 2015-01-30 | 246,500 | — | $0 | 246,500 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2015-01-28 | 2015-01-30 | 43,500 | — | $0 | 217,126 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | P Buy | 2014-11-28 | 2014-12-01 | 6,000 | $16.67 | $100.0K | 172,626 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2014-05-19 | 2014-05-21 | 295,800 | — | $0 | 295,800 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2014-05-19 | 2014-05-21 | 96,000 | $32.22 | $3.09M | 166,626 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 17,293 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 409 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion | 2014-02-11 | 2014-02-11 | 17,702 | — | $0 | 71,035 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2013-12-17 | 2014-02-11 | 99,583 | — | $0 | 99,583 | SEC↗ |